| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| D003520 | Cyclophosphamide | SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004 
 | 
| D004041 | Dietary Fats | Dietary Fats results in increased expression of SCUBE2 mRNA | increases expression | 18042831 
 | 
| D004317 | Doxorubicin | SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004 
 | 
| D005472 | Fluorouracil | SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004 
 | 
| D017239 | Paclitaxel | SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004 
 | 
| C041786 | palm oil | palm oil results in increased expression of SCUBE2 mRNA | increases expression | 18042831 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000230 | Adenocarcinoma |  | Doxorubicin | 4.83 | 17418594 | 
| MESH:D000230 | Adenocarcinoma |  | Fluorouracil | 4.83 | 17638652 | 
| MESH:D000419 | Albuminuria |  | Doxorubicin | 4.93 | 21441931 | 
| MESH:D000740 | Anemia |  | Fluorouracil | 4.02 | 17963324	16511603	15504547 | 
| MESH:D001161 | Arteriosclerosis |  | Cyclophosphamide | 11.76 | 15014928 | 
| MESH:D001161 | Arteriosclerosis |  | Dietary Fats | 11.76 | 15238619 | 
| MESH:D019046 | Bone Marrow Neoplasms |  | Doxorubicin | 5.22 | 14601052 | 
| MESH:D001859 | Bone Neoplasms |  | Paclitaxel | 4.92 | 15867366 | 
| MESH:D001932 | Brain Neoplasms |  | Doxorubicin | 4.11 | 17150277 | 
| MESH:D001943 | Breast Neoplasms |  | Cyclophosphamide | 2.45 | 15136595	11325840	15093573	18323546	17020986	17388661	16978400	18234424	12006526 | 
| MESH:D001943 | Breast Neoplasms |  | Dietary Fats | 2.45 | 20435547 | 
| MESH:D001943 | Breast Neoplasms |  | Doxorubicin | 2.45 | 15692762	16115903	18234424	19526202	16322301	17369602	17426702	15939500	18382427	16096432	15993339	18628466	15567936	17983394	11325840	16264153	15136595	18695136	16826403	15668708	16935488	15994142	15634643	16595493 | 
| MESH:D001943 | Breast Neoplasms |  | Fluorouracil | 2.45 | 18357371	16557594	19217205	16595493	16110121	15136595	18608205 | 
| MESH:D001943 | Breast Neoplasms |  | Paclitaxel | 2.45 | 16115903	15136595	18234424	16244791	11325840	18323546	18223236	16273361 | 
| MESH:D002276 | Carcinoid Tumor |  | Doxorubicin | 14.15 | 16051944 | 
| MESH:D002276 | Carcinoid Tumor |  | Fluorouracil | 14.15 | 16051944 | 
| MESH:D002277 | Carcinoma |  | Fluorouracil | 3.82 | 17121937 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Cyclophosphamide | 7.02 | 19701751 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Doxorubicin | 7.02 | 18059187	16023760	17876044	16234567 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Fluorouracil | 7.02 | 16799960	17045692	16332177	17088986	18930000	17971768 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Paclitaxel | 7.02 | 16313753 | 
| MESH:D018827 | Carcinoma, Lewis Lung |  | Cyclophosphamide | 5.35 | 16152834 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Cyclophosphamide | 11.64 | 16201981 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Doxorubicin | 11.64 | 1485588	16201981 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Fluorouracil | 11.64 | 18695887 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Doxorubicin | 5.10 | 6189445 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Fluorouracil | 5.10 | 16280240	17066447	18986760	16757204 | 
| MESH:D009202 | Cardiomyopathies |  | Doxorubicin | 3.72 | 16109756	15476868	16952015	16364871	17974986	17351982	17928571	16731534	15792986	18627295	16242529	16651473	17382496	17007740	17924179	16612575	16269455	17131338	16278810	17308081	15505089	17329180	15811867	17519947	16455267 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Doxorubicin | 3.03 | 16243910	17334414 | 
| MESH:D003110 | Colonic Neoplasms |  | Fluorouracil | 2.27 | 17725105	18772588	15001691	17169374	16510598	17016597	16340194	17287894	17018589	17172411 | 
| MESH:D015179 | Colorectal Neoplasms |  | Doxorubicin | 3.68 | 18259882	18802399 | 
| MESH:D015179 | Colorectal Neoplasms |  | Fluorouracil | 3.68 | 17094418	20501625	15289873	16303861	17016601	18802399	17255274	18383874	17594712	18509181	16331619	16391804	17401013	16524972	14970324	17695437	18448328	17454858	15148649	16282729	18949393	18288408 | 
| MESH:D015179 | Colorectal Neoplasms |  | Paclitaxel | 3.68 | 18802399 | 
| MESH:D003556 | Cystitis |  | Cyclophosphamide | 5.51 | 12913760	15276878	16651033	18372110	16614059	12388444	18433785	18483878	10498854	18295254	18093676	10700343	16413132	16989017	17010015	11948286	18710439	17979934	15643279	12161096 | 
| MESH:D007644 | Darier Disease |  | Fluorouracil | 5.25 | 16733453 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Cyclophosphamide | 4.33 | 11751995	10990075	15331540 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Cyclophosphamide | 3.29 | 18772604 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Doxorubicin | 2.51 | 17416283 | 
| MESH:D004362 | Drug Toxicity |  | Doxorubicin | 3.90 | 18602426 | 
| MESH:D050171 | Dyslipidemias |  | Dietary Fats | 3.67 | 18367378 | 
| MESH:D016889 | Endometrial Neoplasms |  | Doxorubicin | 3.64 | 17359293 | 
| MESH:D004719 | Endomyocardial Fibrosis |  | Doxorubicin | 5.68 | 18037988 | 
| MESH:D004802 | Eosinophilia |  | Cyclophosphamide | 4.63 | 11006010 | 
| MESH:D004938 | Esophageal Neoplasms |  | Fluorouracil | 5.03 | 16337965	16481741	16785472	17638652	15173087 | 
| MESH:D004938 | Esophageal Neoplasms |  | Paclitaxel | 5.03 | 16481741 | 
| MESH:D005234 | Fatty Liver |  | Dietary Fats | 3.56 | 19004024	18296743	19551842	17967931 | 
| MESH:D018222 | Fibromatosis, Aggressive |  | Doxorubicin | 5.05 | 19069698 | 
| MESH:D005355 | Fibrosis |  | Dietary Fats | 3.94 | 18296743 | 
| MESH:D005909 | Glioblastoma |  | Doxorubicin | 3.54 | 17150277 | 
| MESH:D005910 | Glioma |  | Fluorouracil | 2.97 | 16145905 | 
| MESH:D018316 | Gliosarcoma |  | Cyclophosphamide | 5.98 | 11389073 | 
| MESH:D006086 | Graft vs Host Disease |  | Cyclophosphamide | 5.45 | 11014644	16376943	15172196 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Doxorubicin | 8.60 | 15692506 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Fluorouracil | 8.60 | 18337622	15162350	15102660 | 
| MESH:D006331 | Heart Diseases |  | Doxorubicin | 3.69 | 16330681	16244371	16244372	18006777	16879835	16144979	12587719	17888722	16495754	17875725	16707910	18674790	14766674 | 
| MESH:D006333 | Heart Failure |  | Doxorubicin | 3.52 | 17481944 | 
| MESH:D006394 | Hemangiosarcoma |  | Doxorubicin | 4.23 | 15692506 | 
| MESH:D006467 | Hemophilia A |  | Cyclophosphamide | 5.71 | 11918545 | 
| MESH:D006504 | Hepatic Veno-Occlusive Disease |  | Cyclophosphamide | 6.05 | 14986274 | 
| MESH:D006689 | Hodgkin Disease |  | Cyclophosphamide | 8.67 | 16135485	17606976 | 
| MESH:D006689 | Hodgkin Disease |  | Doxorubicin | 8.67 | 17606976	15147373	18501091 | 
| MESH:D006937 | Hypercholesterolemia |  | Dietary Fats | 3.92 | 21332399 | 
| MESH:D006949 | Hyperlipidemias |  | Dietary Fats | 3.97 | 21332399 | 
| MESH:D007154 | Immune System Diseases |  | Cyclophosphamide | 5.85 | 16076520 | 
| MESH:D007248 | Infertility, Male |  | Cyclophosphamide | 3.82 | 16517039	7193160 | 
| MESH:D007249 | Inflammation |  | Dietary Fats | 2.57 | 20412841 | 
| MESH:D007333 | Insulin Resistance |  | Dietary Fats | 3.30 | 18457598	11836018 | 
| MESH:D007674 | Kidney Diseases |  | Doxorubicin | 3.21 | 15369732	16775033	15699352 | 
| MESH:D007676 | Kidney Failure, Chronic |  | Doxorubicin | 4.48 | 16707910 | 
| MESH:D007680 | Kidney Neoplasms |  | Fluorouracil | 3.57 | 16985049 | 
| MESH:D007938 | Leukemia |  | Cyclophosphamide | 3.62 | 10602166 | 
| MESH:D004915 | Leukemia, Erythroblastic, Acute |  | Doxorubicin | 5.68 | 16085563 | 
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell |  | Cyclophosphamide | 3.61 | 18587576	17802794	17008537	18172266	17296974	17658394 | 
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |  | Cyclophosphamide | 4.32 | 10373061 | 
| MESH:D007970 | Leukopenia |  | Cyclophosphamide | 5.43 | 10052129	11830472 | 
| MESH:D008080 | Liposarcoma |  | Paclitaxel | 5.17 | 17353645 | 
| MESH:D008103 | Liver Cirrhosis |  | Dietary Fats | 3.03 | 18296743 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Doxorubicin | 2.15 | 16595196	16439617 | 
| MESH:D008113 | Liver Neoplasms |  | Fluorouracil | 2.57 | 16603448	17045692	15113037	18383874 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Doxorubicin | 3.19 | 17085340	16842330 | 
| MESH:D008175 | Lung Neoplasms |  | Doxorubicin | 2.75 | 17418594	6189445 | 
| MESH:D008175 | Lung Neoplasms |  | Fluorouracil | 2.75 | 15246190 | 
| MESH:D008178 | Lupus Erythematosus, Cutaneous |  | Fluorouracil | 5.25 | 15086387 | 
| MESH:D008223 | Lymphoma |  | Cyclophosphamide | 8.62 | 12854902 | 
| MESH:D008223 | Lymphoma |  | Doxorubicin | 8.62 | 16098063 | 
| MESH:D016393 | Lymphoma, B-Cell |  | Cyclophosphamide | 4.95 | 16675587 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Cyclophosphamide | 16.29 | 11911406 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Doxorubicin | 16.29 | 17654614 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Paclitaxel | 16.29 | 14749477 | 
| MESH:D016399 | Lymphoma, T-Cell |  | Doxorubicin | 4.98 | 15621674 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Doxorubicin | 3.21 | 15458769 | 
| MESH:D008545 | Melanoma |  | Doxorubicin | 3.81 | 16827129 | 
| MESH:D008545 | Melanoma |  | Paclitaxel | 3.81 | 12025231	16342250	12040289 | 
| MESH:D008546 | Melanoma, Experimental |  | Cyclophosphamide | 5.22 | 16388313 | 
| MESH:D008654 | Mesothelioma |  | Doxorubicin | 3.16 | 17638057 | 
| MESH:D028361 | Mitochondrial Diseases |  | Doxorubicin | 4.83 | 15792986 | 
| MESH:D009062 | Mouth Neoplasms |  | Fluorouracil | 3.87 | 18986760	16757204 | 
| MESH:D052016 | Mucositis |  | Doxorubicin | 5.25 | 17415656 | 
| MESH:D009101 | Multiple Myeloma |  | Paclitaxel | 3.90 | 14749477 | 
| MESH:D009203 | Myocardial Infarction |  | Doxorubicin | 3.05 | 19429709	15857846 | 
| MESH:D009362 | Neoplasm Metastasis |  | Doxorubicin | 6.48 | 18259882 | 
| MESH:D009362 | Neoplasm Metastasis |  | Paclitaxel | 6.48 | 15867366 | 
| MESH:D009369 | Neoplasms |  | Cyclophosphamide | 5.87 | 18854779 | 
| MESH:D009369 | Neoplasms |  | Fluorouracil | 5.87 | 18239605	18600527	16928823 | 
| MESH:D009401 | Nephrosis |  | Doxorubicin | 5.19 | 16899518	16636307 | 
| MESH:D009404 | Nephrotic Syndrome |  | Doxorubicin | 4.29 | 16889571	15640375 | 
| MESH:D009447 | Neuroblastoma |  | Cyclophosphamide | 7.69 | 16115947	8761367	15176712 | 
| MESH:D009447 | Neuroblastoma |  | Doxorubicin | 7.69 | 15555623 | 
| MESH:D017599 | Neuroectodermal Tumors |  | Cyclophosphamide | 5.35 | 8761367	12837982 | 
| MESH:D020258 | Neurotoxicity Syndromes |  | Fluorouracil | 3.64 | 16436463 | 
| MESH:D009503 | Neutropenia |  | Cyclophosphamide | 4.68 | 8291058 | 
| MESH:D009765 | Obesity |  | Dietary Fats | 2.34 | 20132043	17217161	19632207	21332399	18674790	18457598	11836018	16723640	20518802 | 
| MESH:D009845 | Oligospermia |  | Cyclophosphamide | 5.17 | 16517039 | 
| MESH:D010014 | Osteolysis |  | Paclitaxel | 5.44 | 15867366 | 
| MESH:D012516 | Osteosarcoma |  | Doxorubicin | 4.37 | 15930896 | 
| MESH:D010051 | Ovarian Neoplasms |  | Paclitaxel | 3.06 | 11161223 | 
| MESH:D010146 | Pain |  | Cyclophosphamide | 3.89 | 12161096	18093676 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Cyclophosphamide | 5.92 | 11332152 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Fluorouracil | 5.92 | 19003803	16929163	16500647	15113037 | 
| MESH:D003557 | Phyllodes Tumor |  | Doxorubicin | 5.68 | 17983394 | 
| MESH:D010997 | Pleural Neoplasms |  | Doxorubicin | 5.68 | 17638057 | 
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |  | Cyclophosphamide | 3.96 | 21297632 | 
| MESH:D011471 | Prostatic Neoplasms |  | Cyclophosphamide | 2.13 | 17136230 | 
| MESH:D011471 | Prostatic Neoplasms |  | Doxorubicin | 2.13 | 18437689	16888761	15897917	15749863	16729912	16868541 | 
| MESH:D011471 | Prostatic Neoplasms |  | Fluorouracil | 2.13 | 19082440	18626508 | 
| MESH:D011471 | Prostatic Neoplasms |  | Paclitaxel | 2.13 | 17172428	16729912	16356831	17136230 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Cyclophosphamide | 3.38 | 16636934 | 
| MESH:D012004 | Rectal Neoplasms |  | Fluorouracil | 4.30 | 16160472	18286688	15538739	18722050 | 
| MESH:D051437 | Renal Insufficiency |  | Doxorubicin | 4.64 | 17922066 | 
| MESH:D012509 | Sarcoma |  | Doxorubicin | 4.29 | 16767912	17203757	15625365	15675481	17710206	18313854 | 
| MESH:D012512 | Sarcoma, Ewing's |  | Doxorubicin | 4.62 | 14601052	16326096 | 
| MESH:D012514 | Sarcoma, Kaposi |  | Doxorubicin | 5.25 | 17846226 | 
| MESH:D012595 | Scleroderma, Systemic |  | Cyclophosphamide | 5.17 | 16636934 | 
| MESH:D012878 | Skin Neoplasms |  | Doxorubicin | 3.08 | 15692506 | 
| MESH:D012983 | Soft Tissue Neoplasms |  | Doxorubicin | 4.98 | 17203757	16767912	15625365 | 
| OMIM:102530 | SPERMATOGENIC FAILURE 6 |  | Cyclophosphamide | 5.98 | 16517039 | 
| MESH:D013274 | Stomach Neoplasms |  | Fluorouracil | 2.81 | 18396642	19084572	18567086	17498489	17522103	16951190	17172411	15786421	19015929	16424979 | 
| MESH:D013274 | Stomach Neoplasms |  | Paclitaxel | 2.81 | 18506536	18396642 | 
| MESH:D015173 | Supratentorial Neoplasms |  | Cyclophosphamide | 5.52 | 12837982 | 
| MESH:D024801 | Tauopathies |  | Paclitaxel | 5.27 | 16930453 | 
| MESH:D013964 | Thyroid Neoplasms |  | Doxorubicin | 3.61 | 17909728	16010429 | 
| MESH:D014062 | Tongue Neoplasms |  | Fluorouracil | 4.29 | 16280240 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Cyclophosphamide | 5.84 | 14692829 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Doxorubicin | 5.84 | 17653716 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | Fluorouracil | 4.18 | 16803524 | 
| MESH:D018487 | Ventricular Dysfunction, Left |  | Doxorubicin | 4.64 | 17678736	17334414	17638931	16364871 | 
| MESH:D015430 | Weight Gain |  | Dietary Fats | 4.02 | 16723640 |